Rolando Herrero
#139,137
Most Influential Person Now
Researcher
Rolando Herrero's AcademicInfluence.com Rankings
Rolando Herrerocomputer-science Degrees
Computer Science
#6570
World Rank
#6927
Historical Rank
Computational Linguistics
#1165
World Rank
#1179
Historical Rank
Machine Learning
#2181
World Rank
#2209
Historical Rank
Artificial Intelligence
#2447
World Rank
#2488
Historical Rank
Download Badge
Computer Science
Rolando Herrero's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Rolando Herrero Influential?
(Suggest an Edit or Addition)Rolando Herrero's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (2003) (6086)
- Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (2003) (1255)
- Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis (2005) (1085)
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium (2009) (954)
- Epidemiology and Molecular Pathology of Gallbladder Cancer (2001) (768)
- Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study (2002) (660)
- Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. (2006) (656)
- Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. (2002) (652)
- Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study (2002) (649)
- Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. (2000) (611)
- Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. (2007) (571)
- The carcinogenicity of human papillomavirus types reflects viral evolution. (2005) (565)
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. (2016) (564)
- HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. (2000) (556)
- Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. (2008) (460)
- Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide (2006) (413)
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica (2013) (412)
- A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. (2005) (394)
- Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study (2003) (393)
- Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. (2002) (386)
- Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. (2007) (383)
- Oral cancer in southern India: The influence of smoking, drinking, paan‐chewing and oral hygiene (2002) (368)
- Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. (2005) (368)
- Epidemiology of HPV infection among Mexican women with normal cervical cytology (2001) (365)
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. (2010) (353)
- Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. (2010) (347)
- Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. (2000) (331)
- The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis (2004) (302)
- Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study (2004) (297)
- Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature (2010) (293)
- Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. (2002) (285)
- A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium (2011) (278)
- HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica (2001) (268)
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine (2011) (259)
- An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). (2001) (258)
- Risk factors for cancer of the oral cavity and oro-pharynx in Cuba (2001) (256)
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial (2011) (255)
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. (2015) (252)
- Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. (2011) (247)
- Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci (2005) (243)
- Risk factors for cervical cancer in Thailand: a case-control study. (1998) (241)
- Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. (2010) (235)
- Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study (2004) (226)
- Human papillomavirus type 16 variants and risk of cervical cancer. (2001) (225)
- A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. (2010) (224)
- Human papillomavirus infection and cervical cancer in Latin America. (1989) (219)
- An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. (2019) (216)
- Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. (2013) (214)
- CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3: Results from a Histological Review of Population-Based Cervical Samples (2007) (213)
- Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. (1997) (211)
- Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies (1998) (211)
- Parity as a risk factor for cervical cancer. (1989) (208)
- Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners (2002) (203)
- Utility of liquid‐based cytology for cervical carcinoma screening (1999) (201)
- Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial (2013) (200)
- Sexual Behavior, Condom Use, and Human Papillomavirus: Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys (2006) (199)
- Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries (2009) (196)
- Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium (2013) (195)
- Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland (2003) (193)
- Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. (2002) (186)
- Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case‐control study (2003) (182)
- Present status of human papillomavirus vaccine development and implementation. (2015) (181)
- Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. (2008) (180)
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. (2011) (178)
- Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection (2004) (176)
- Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. (2010) (173)
- Oral hygiene, dentition, sexual habits and risk of oral cancer (2000) (170)
- Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high‐risk population (1990) (170)
- Comparisons of HPV DNA detection by MY09/11 PCR methods (2002) (169)
- Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. (2015) (169)
- European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. (2015) (169)
- Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. (2009) (166)
- Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. (2008) (165)
- Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study (2009) (165)
- Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain (2003) (162)
- Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries (2017) (160)
- High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease (2007) (159)
- Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses (2005) (156)
- Human papillomavirus infection among women in South and North Vietnam (2003) (156)
- The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. (2011) (155)
- Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. (2011) (153)
- HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. (2011) (153)
- Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys (2006) (152)
- Family history of cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (2009) (152)
- A study of the impact of adding HPV types to cervical cancer screening and triage tests. (2005) (151)
- Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. (2003) (151)
- Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium (2011) (149)
- Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67 (2011) (149)
- A case-control study of nutrient status and invasive cervical cancer. I. Dietary indicators. (1991) (147)
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. (2008) (147)
- World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen‐and‐treat strategies to prevent cervical cancer (2016) (145)
- The fight against gastric cancer - the IARC Working Group report. (2014) (143)
- A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. (2003) (142)
- Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. (2004) (140)
- Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. (2004) (140)
- Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica (2003) (140)
- Prevalence of human papillomavirus infection in women in Busan, South Korea (2003) (135)
- Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. (2009) (133)
- The ma le factor in the etiology of cervical cancer among sexually monogamous women (1989) (133)
- Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. (2015) (131)
- Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia (2013) (131)
- Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer (2016) (127)
- Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case‐control studies from 27 countries (2015) (127)
- Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. (2011) (126)
- Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) (2013) (125)
- Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer (2010) (124)
- Prevention Strategies for Gastric Cancer: A Global Perspective (2014) (123)
- Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. (2006) (120)
- Oral contraceptive use and risk of invasive cervical cancer. (1990) (119)
- Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:: A Population-Based Study (2003) (115)
- Age-related changes of the cervix influence human papillomavirus type distribution. (2006) (115)
- Screening for cervical cancer in Latin America: a case-control study. (1992) (114)
- National Institutes of Health Consensus Development Conference Statement on Cervical Cancer (1997) (114)
- Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys (2010) (113)
- Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing (1997) (113)
- Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. (2009) (110)
- Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment (2016) (109)
- Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies (2009) (107)
- Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. (2001) (107)
- Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. (2006) (106)
- Oral cancer in Southern India: the influence of body size, diet, infections and sexual practices (2003) (105)
- Cervicovaginal microbiome and natural history of HPV in a longitudinal study (2020) (105)
- Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. (2012) (104)
- The Cervical Microbiome over 7 Years and a Comparison of Methodologies for Its Characterization (2012) (103)
- Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. (2009) (103)
- Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. (2010) (99)
- Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America (2013) (99)
- Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials (2010) (97)
- Differences in the risk of cervical cancer and human papillomavirus infection by education level (2009) (97)
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies (2018) (97)
- A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators. (1991) (96)
- Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months. (2014) (94)
- Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. (2016) (94)
- A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection (2012) (93)
- Oral and oropharyngeal cancer in Spain: influence of dietary patterns (2003) (93)
- Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men. (2005) (93)
- Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. (2014) (90)
- Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. (2003) (88)
- Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. (2009) (88)
- A Comparison of Cervical and Vaginal Human Papillomavirus (2007) (88)
- Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. (2013) (86)
- Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica (2004) (86)
- An updated natural history model of cervical cancer: derivation of model parameters. (2014) (85)
- Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. (2004) (85)
- Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods (2008) (84)
- Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97 (2008) (83)
- Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women. (2008) (83)
- Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years (2010) (82)
- Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica (2007) (81)
- Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors (2005) (81)
- Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus (2002) (80)
- Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer (2004) (77)
- Sequence Imputation of HPV16 Genomes for Genetic Association Studies (2011) (77)
- p53 polymorphism and risk of cervical cancer (1998) (76)
- A population-based study of vaginal human papillomavirus infection in hysterectomized women. (2004) (76)
- European Code against Cancer, 4th Edition: Cancer screening. (2015) (75)
- Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. (2010) (75)
- The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review (2018) (73)
- HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas (2005) (73)
- Diet and risk of oral and pharyngeal cancer. An Italian case–control study (2001) (72)
- Risk factors for cervical cancer by histology. (1993) (71)
- A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. (2003) (70)
- Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. (2010) (70)
- Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. (2002) (68)
- Invasive cervical cancer and smoking in Latin America. (1989) (68)
- Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries. (2006) (68)
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial (2018) (68)
- Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. (2007) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection (2010) (67)
- Smoking and Passive Smoking in Cervical Cancer Risk: Pooled Analysis of Couples from the IARC Multicentric Case–Control Studies (2011) (66)
- The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life (2007) (65)
- Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: Analysis from the IARC multinational case–control study (2006) (63)
- Human papillomavirus and cancer of the upper aerodigestive tract (2003) (63)
- Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Infection Among Middle-Age Women in Brazil and the Philippines (2001) (63)
- Cervical cancer in Central and South America: Burden of disease and status of disease control. (2016) (62)
- Recommendations for cervical cancer prevention in Latin America and the Caribbean. (2008) (62)
- A case-control study of serum folate levels and invasive cervical cancer. (1991) (60)
- TP53 polymorphism, HPV infection, and risk of cervical cancer. (2001) (60)
- Cervical Infection With Chlamydia trachomatis and Neisseria gonorrhoeae in Women From Ten Areas in Four Continents: A Cross-Sectional Study (2007) (60)
- Epidemiologic determinants of vaginal pH. (1999) (58)
- Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70 (2013) (58)
- Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. (2015) (58)
- A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. (2011) (58)
- Human papillomavirus and cancer (1999) (58)
- Human Papillomavirus Types by Age in Cervical Cancer Precursors: Predominance of Human Papillomavirus 16 in Young Women (2009) (57)
- Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study (2017) (57)
- New approaches to cervical cancer screening in Latin America and the Caribbean. (2008) (57)
- Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. (2001) (57)
- Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. (2008) (56)
- Cervicography screening for cervical cancer among 8460 women in a high-risk population. (1999) (56)
- Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial. (2020) (54)
- Antibodies against high‐risk human papillomavirus proteins as markers for invasive cervical cancer (2014) (54)
- Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys (2010) (54)
- Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®). (2012) (52)
- Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits (2003) (50)
- Stability of archived liquid‐based cervical cytologic specimens (2003) (50)
- HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica (2000) (49)
- Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. (2011) (49)
- Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association (1990) (49)
- Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures. (1999) (48)
- HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays (2013) (48)
- Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans (2018) (47)
- Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori–Associated Gastroduodenal Pathologies (2008) (47)
- Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. (2011) (47)
- Epidemiology of cervical cancer. (1996) (47)
- Role of paan chewing and dietary habits in cervical carcinoma in Chennai, India (2003) (46)
- Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. (2013) (46)
- EUROGIN 2008 roadmap on cervical cancer prevention (2009) (45)
- An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case–control studies (2011) (45)
- Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. (2012) (45)
- Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study. (2019) (44)
- Prevention of gastric cancer. (2014) (44)
- Determinants of seropositivity among HPV-16/18 DNA positive young women (2010) (43)
- Correlates of IL-10 and IL-12 Concentrations in Cervical Secretions (2003) (43)
- Short Communication Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica (2004) (43)
- European Code against Cancer 4th Edition: Infections and Cancer. (2015) (42)
- Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage (2016) (41)
- Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. (2016) (40)
- Family history as a co‐factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States (2005) (40)
- Human papillomavirus vaccine should be given before sexual debut for maximum benefit. (2007) (39)
- Innovations in understanding the biology of cervical cancer (2003) (39)
- Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer (2012) (39)
- Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration (2020) (38)
- Comparison of Ophthalmic Sponges for Measurements of Immune Markers from Cervical Secretions (2004) (38)
- Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment (2012) (37)
- Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses (2013) (37)
- Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. Commentaries (2007) (36)
- Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. (2011) (36)
- Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes (2016) (36)
- Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. (2020) (36)
- The relations between cervical cancer and serological markers of nutritional status. (1994) (36)
- Implementation of HPV‐testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina (2015) (35)
- Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland (2017) (32)
- Genetic Variants in Nicotine Addiction and Alcohol Metabolism Genes, Oral Cancer Risk and the Propensity to Smoke and Drink Alcohol: A Replication Study in India (2014) (32)
- Type-Specific Seroprevalence of Herpes Simplex Virus Type 2 and Associated Risk Factors in Middle-Aged Women From 6 Countries: The IARC Multicentric Study (2007) (32)
- Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial (2015) (31)
- Low risk of type‐specific carcinogenic HPV re‐appearance with subsequent cervical intraepithelial neoplasia grade 2/3 (2012) (31)
- Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium (2010) (30)
- Performance of a semiautomated papanicolaou smear screening system (1998) (30)
- Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial. (2020) (29)
- Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica (2010) (29)
- Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica. (1998) (29)
- Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). (2018) (29)
- Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens (2007) (29)
- Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle. (2009) (28)
- Common Genetic Variation in TP53 and Risk of Human Papillomavirus Persistence and Progression to CIN3/Cancer Revisited (2009) (28)
- Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus. (2014) (28)
- Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing. (2014) (27)
- [New paradigms and challenges in cervical cancer prevention and control in Latin America]. (2010) (26)
- Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. (2013) (26)
- Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. (2019) (26)
- Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. (2005) (25)
- Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus (2014) (25)
- Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer (2013) (24)
- Determinants of the geographic variation of invasive cervical cancer in Costa Rica. (1993) (24)
- Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naïve Women in HPV Vaccine Trials (2012) (24)
- Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106. (2007) (23)
- Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays (2014) (23)
- Epidemiology of Genital Chlamydia trachomatis Infection Among Young Women in Costa Rica (2008) (23)
- Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia (2016) (23)
- Chapter 1. Summary of IARC/NCI Expert Meeting on Primary End-points for Prophylactic HPV Vaccine Trials (2014) (22)
- A Sex-Specific Association between a 15q25 Variant and Upper Aerodigestive Tract Cancers (2011) (22)
- HPV testing and visual inspection for cervical cancer screening in resource‐poor regions (2003) (22)
- Chlamydia trachomatis and cervical squamous cell carcinoma. (2001) (22)
- A case–control study of endogenous hormones and cervical cancer (2004) (21)
- Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. (2002) (21)
- Cervical cancer screening in Europe. What next? (2000) (20)
- Risk factors for invasive carcinoma of the uterine cervix in Latin America. (1990) (20)
- Using Prior Information from the Medical Literature in GWAS of Oral Cancer Identifies Novel Susceptibility Variant on Chromosome 4 - the AdAPT Method (2012) (19)
- Evaluation of the FTA Carrier Device for Human Papillomavirus Testing in Developing Countries (2012) (19)
- Collection of Cervical Secretions Does Not Adversely Affect Pap Smears Taken Immediately Afterward (1998) (19)
- Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. (2014) (18)
- Genetic Admixture and Population Substructure in Guanacaste Costa Rica (2010) (18)
- Immunosuppression in cervical cancer with special reference to arginase activity. (2014) (18)
- Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections. (2016) (18)
- Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure (2011) (18)
- Human Papillomavirus Testing as a Screening Tool for Cervical Cancer—Reply (2000) (17)
- Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. (2002) (17)
- Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol (2020) (17)
- Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45 (2007) (16)
- Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay (2019) (16)
- Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? (2013) (16)
- Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. (2015) (16)
- Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica (1999) (16)
- Treatability by Cryotherapy in a Screen-and-Treat Strategy (2009) (15)
- Switch from cytology‐based to human papillomavirus test‐based cervical screening: Implications for colposcopy (2012) (15)
- Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data (2009) (15)
- A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica (2003) (15)
- Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials. (2019) (15)
- Neither one‐time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer (2009) (15)
- Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes (2019) (15)
- Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. (2014) (14)
- Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries (2016) (14)
- Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. (1999) (14)
- Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography. (2003) (14)
- Stability of archived liquid‐based cytologic specimens (2003) (13)
- Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study (2020) (12)
- Establishment and Operation of a Biorepository for Molecular Epidemiologic Studies in Costa Rica (2010) (12)
- Preparing Digitized Cervigrams for Colposcopy Research and Education: Determination of Optimal Resolution and Compression Parameters (2006) (12)
- Recent progress in gastric cancer prevention. (2021) (12)
- BMI throughout life, intake of vitamin supplements and oral cancer in Spain. (2002) (11)
- Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties (2010) (11)
- Erratum: Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies (Journal of Clinical Microbiology (1998) 36:11 (3248-3254)) (1999) (11)
- Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE). (2019) (11)
- Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine. (2018) (11)
- Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination (2018) (10)
- Effect of vaccination against oral HPV-16 infection in high school students in the city of Cali, Colombia (2019) (10)
- The Natural History of Oral Human Papillomavirus in Young Costa Rican Women (2017) (10)
- Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review (2020) (10)
- Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sample (2018) (10)
- Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. (2021) (10)
- Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18‐Year follow‐up of the Guanacaste cohort (2017) (10)
- Cervicography Screening for Cervical Cancer Among 8,460 Women in a High-Risk Population (1999) (10)
- [The risk factors of invasive carcinoma of the cervix uteri in Latin America]. (1990) (9)
- Determinants and Correlation of Systemic and Cervical Concentrations of Total IgA and IgG (2009) (9)
- Considerations for conducting epidemiologic case-control studies of cancer in developing countries. (1991) (8)
- molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history (2022) (8)
- Hepatitis C virus seroprevalence in the general female population from 8 countries. (2015) (8)
- T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study (2018) (8)
- Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy (2019) (8)
- An Evaluation by Midwives and Gynecologists of Treatability of Cervical Lesions by Cryotherapy Among Human Papillomavirus-Positive Women (2009) (8)
- Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial (2022) (8)
- Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels (2012) (8)
- PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection. (2005) (8)
- Correction: A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium (2011) (7)
- Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. (2015) (7)
- TP 53 Polymorphism , HPV Infection , and Risk of Cervical Cancer (2001) (7)
- Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay (2014) (7)
- Herpes Simplex Virus Type-2 Seropositivity Among Ever Married Women in South and North Vietnam: A Population-Based Study (2009) (7)
- Performance of Direct Visual Inspection of the Cervix with Acetic Acid and Magnification in a Previously Screened Population (2004) (7)
- Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer (2019) (7)
- Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. (2020) (7)
- Alterations of T‐cell surface markers in older women with persistent human papillomavirus infection (2011) (6)
- Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan (2021) (6)
- Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile (2020) (6)
- Codetection of a mixed population of candHPV62 containing wild-type and disrupted E1 open-reading frame in a 45-year-old woman with normal cytology. (2004) (6)
- Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America (2022) (5)
- Smoking behavior and its determinants among women in Concordia, Argentina. (2004) (5)
- Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial (2021) (5)
- Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies (1999) (5)
- Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus (2019) (5)
- Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting. (2012) (5)
- Prevention of cervical cancer in women's hands: Mexico leads the way (2011) (5)
- Different human papillomavirus types share early natural history transitions in immunocompetent women (2022) (4)
- Right-Sided Ectocervical Lesions May Be Associated with False-Negative Cytology Among Women with Histologic Cervical Intraepithelial Neoplasia 2 or 3 (2003) (4)
- A Randomized Trial Comparing 14-Day Triple, 10-Day Sequential, and 5-Day Concomitant Therapy to Eradicate Helicobacter pylori in Seven Latin American Populations (2011) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection. (2020) (4)
- Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based Study (2021) (3)
- Elevated levels of p53 protein in adrenocortical carcinomas from Costa Rica. (1995) (3)
- Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical HPV Infection 1,2,3,4 (2011) (3)
- Re: Muñoz et al., “Against which human papillomavirus types shall we vaccinate and screen? The international perspective.” Int J Cancer 2004;111:278–85 (2005) (3)
- Geographic variation of the prevalence of Kaposi's sarcoma-associated herpesvirus and risk factors for transmission in women from 8 countries in four continents (2009) (3)
- Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT). (2020) (3)
- Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials. (2020) (3)
- Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes. (2021) (2)
- 1046 Predictors of Success of Helicobacter pylori Eradication Treatment in a Multicentric Randomized Clinical Trial (SWOG S0701) in Latin America (2012) (2)
- Su1673 H. pylori Recurrence One Year After Eradication Treatment in a Population Randomized Trial (SWOG S0701) in Seven Latin American Sites (2012) (2)
- Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations? (2020) (2)
- Soluble Interleukin 2 Receptor Levels and Cervical Neoplasia (1999) (2)
- Reproducibility of a Rapid Human Papillomavirus Test at Different Levels of the Healthcare System in Tanzania: The AISHA Study (2020) (2)
- Population-Based Strategies for Helicobacter pylori -Associated Disease Management: Latin American Perspective (2016) (2)
- Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. (2022) (2)
- Evidence for Chlamydia trachomatis as an HPV cofactor in the etiology of invasive cervical cancer in Brazil and the Phillipines (2000) (2)
- Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America (2012) (2)
- Comparison of immediate colposcopy, repeat conventional cytology and high‐risk human papillomavirus testing for the clinical management of atypical squamous cells of undetermined significance cytology in routine health services of Medellin, Colombia: The ASCUS‐COL trial (2020) (2)
- Impact of operational factors on HPV positivity rates in an HPV‐based screening study in Colombia (2018) (2)
- [Elimination of cervical cancer in Latin America]. (2018) (2)
- Etiology of cervical cancer ( C 53 ) in Central and South America (2016) (2)
- Meta-and Pooled Analyses Total Exposure and Exposure Rate Effects for Alcohol and Smoking and Risk of Head and Neck Cancer : A Pooled Analysis of Case-Control Studies (2009) (2)
- Identification and characterization of two novel human papillomaviruses ( HPVs ) by overlapping PCR : HPV 102 and HPV 106 (2007) (1)
- How do international gastric cancer prevention guidelines influence clinical practice globally? (2020) (1)
- Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial. (2022) (1)
- Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries (2016) (1)
- Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries (2016) (1)
- FAST TRACK EUROGIN 2008 roadmap on cervical cancer prevention (2009) (1)
- How do international gastric cancer prevention guidelines influence clinical practice globally? (2020) (1)
- Lifestyle and dietary factors associated with serologically detected gastric atrophy in a Caucasian population in the GISTAR study (2022) (1)
- HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial (2022) (1)
- Su1677 Risk Factors for Helicobacter pylori Infection in Six Latin American Countries (SWOG Trial S0701) (2012) (1)
- Sexual behaviors and the risk of head and neck cancers (2008) (1)
- Epidemiologic studies of cervical cancer in Costa Rica (1996) (1)
- Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure (2015) (1)
- Eff ect of self-collection of HPV DNA off ered by community health workers at home visits on uptake of screening for cervical cancer ( the EMA study ) : a population-based cluster-randomised trial (2015) (1)
- National Cancer Institute—Costa Rica Studies on Human Papilloma Virus and Cervical Cancer (2013) (1)
- Upper Aerodigestive Tract Cancers (2011) (1)
- Analysis of adverse events of potential autoim- mune aetiology in a large integrated safety database of AS04 adjuvanted vaccines . (2009) (1)
- 590 One-Year Effectiveness and Costs of Six Alternative H. pylori Test/Treat and Retest/Retreat Strategies Using Triple, Concomitant or Sequential Drug Regimens in Seven Latin American Sites (SWOG Trial S0701) (2012) (0)
- Abstract IA12: Risk-assessment in HPV-based cervical cancer screening (2017) (0)
- 30th Annual Meeting • American Society of Preventive Oncology, Bethesda, Maryland • February 26–28, 2006 (2006) (0)
- molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history (2022) (0)
- Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica (2022) (0)
- Increased Circulating Proinflammatory Cytokines in Older Women with Persistent HPV Infection (2008) (0)
- Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens (cid:1) (2007) (0)
- Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study (2020) (0)
- Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al. (2009) (0)
- HPV and cancer 2 Next generation prophylactic human papillomavirus vaccines (2015) (0)
- Upper gastrointestinal endoscopic examination results from the GISTAR pilot study (2017) (0)
- Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial (2022) (0)
- Abstract LB-165: Risk factor prediction models for triage of HR-HPV positive women: The Estampa study (2020) (0)
- Diet and the Risk of Head and Neck Cancer: A Pooled Analysisin the INHANCE Consortium (2012) (0)
- Intrauterine Device Use, Cervical Infection With Human Papillomavirus, and Risk of Cervical Cancer: A Pooled Analysis of 26 Epidemiological Studies (2012) (0)
- Elevated Levels of ~53 Protein in Adrenocortical Carcinomas from (1995) (0)
- Map 4.1, Age-Standardized Cervical Cancer Incidence Rates, 2012 (2015) (0)
- Table 4.1, Performance and Characteristics of Screening Methods (2015) (0)
- Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials (2022) (0)
- Abstract PL05-01: Cervical cancer as an example of gender-associated health inequality. (2012) (0)
- A Comparison of Single and Combined Visual , Cytologic , and Virologic Tests as Screening Strategies in a Region at High Risk of Cervical Cancer 1 (2003) (0)
- Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium (2011) (0)
- ' s report Title : A large , population-based study of age-related associations between vaginal pH and human papillomavirus infection Version : 1 (0)
- Abstract #2132: Alcohol drinking and the risk of head and neck cancer among younger, middle age and older populations (2009) (0)
- The Preliminary Results of GISTAR Pilot Study in Latvia (2016) (0)
- Figure 4.2, Age-Standardized Cervical Cancer Incidence and Mortality Rates per 100,000 Women, by World Bank Income Group (2015) (0)
- Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention in Korea: A Randomized Controlled Clinical Trial (2017) (0)
- The Immune Landscape of Molecular Bacterial Vaginosis and HPV Natural History (2021) (0)
- Figure 4.1, Trends of Age-Standardized Rates of Cervical Cancer Incidence and Mortality in Selected Countries (2015) (0)
- HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial (2022) (0)
- Univariate analysis of HSV-2 antibody seroprevalence by selected reproductive and sociodemographic risk factors (2003) (0)
- ICO Monograph Series on HPV and Cervical Cancer: Latin America and the Caribbean Regional Report Integration of Human Papillomavirus Vaccination and Cervical Cancer Screening in Latin America and the Caribbean (2008) (0)
- Participation Rate in the Gistar Pilot Study: the Results from a Single Recruitment Centre (2015) (0)
- Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study (2022) (0)
- Comparison of the statistical power for three categories of prior odds for the null hypothesis when evaluating the noteworthiness of SNPs by BFDP. (2012) (0)
- Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015 (2023) (0)
- REPRODUCIBLE AND CLINICALLY TRANSLATABLE DEEP NEURAL NETWORKS FOR CANCER SCREENING (2023) (0)
- Papillomavirus Virus-Like Particles of Human Assay for Detection of Antibodies to Enhanced Enzyme-Linked Immunosorbent (2002) (0)
- Excess mortality from COVID 19 in Costa Rica: a registry based study using Poisson regression (2023) (0)
- Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) (2012) (0)
- A Case-Control Study of Serum Folate Levels and Invasive Cervical Cancer1 (2006) (0)
- Intrauterine device and cervical cancer: we need more evidence - Authors' reply (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rolando Herrero?
Rolando Herrero is affiliated with the following schools:
